Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy
- PMID: 3284912
- PMCID: PMC442571
- DOI: 10.1172/JCI113470
Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy
Abstract
We now describe experiments that allow one to determine the consequences of B cell reduction alone vs. those that result from superimposed mild hyperglycemia. Male CD rats underwent a 60% pancreatectomy (Px); controls were sham operated. 1 wk later, either 10% sucrose (SUC) was substituted as fluid supply or tap water was continued (WAT). Plasma glucose and insulin values in Px-WAT remained equal to the sham groups; in Px-SUC the values were euglycemic for 25 d, but then nonfasting plasma glucose rose 15 mg/dl. After 6 wk, B cell mass in Px-WAT was reduced by 45% and non-B cell mass by 57%. In contrast, in Px-SUC both masses were comparable to the sham groups. The insulin response to 27.7 mM glucose was measured using the in vitro perfused pancreas. The responses were reduced in Px-WAT but in proportion to their reduced B cell mass; in contrast, it was 75% less than expected in Px-SUC. Also, the response to arginine given at 16.7 mM glucose was reduced only in Px-SUC. These results show that a lowering of B cell mass that does not result in hyperglycemia has no adverse effect on the remaining B cells. On the other hand, if even mild hyperglycemia develops, B cell function becomes impaired and results in inappropriately reduced insulin stores and insulin responses to marked stimuli.
Similar articles
-
Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).J Clin Invest. 1996 Jan 1;97(1):180-6. doi: 10.1172/JCI118387. J Clin Invest. 1996. PMID: 8550831 Free PMC article.
-
beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia.Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E68-73. doi: 10.1152/ajpendo.2000.279.1.E68. Am J Physiol Endocrinol Metab. 2000. PMID: 10893324
-
Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.Diabetes. 1994 Feb;43(2):173-9. doi: 10.2337/diab.43.2.173. Diabetes. 1994. PMID: 8288040
-
[Glucose toxicity--its mechanism].Nihon Rinsho. 1997 Nov;55 Suppl:872-9. Nihon Rinsho. 1997. PMID: 9434580 Review. Japanese. No abstract available.
-
[Hormonal disorders after radical operations on the pancreas (a review of the literature)].Khirurgiia (Mosk). 1985 Jan;(1):106-11. Khirurgiia (Mosk). 1985. PMID: 3883040 Review. Russian. No abstract available.
Cited by
-
Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.J Clin Invest. 1991 Sep;88(3):767-73. doi: 10.1172/JCI115375. J Clin Invest. 1991. PMID: 1679440 Free PMC article.
-
Thiazolidinediones in prediabetes and early type 2 diabetes: what can be learned about that disease's pathogenesis.Curr Diab Rep. 2009 Jun;9(3):215-20. doi: 10.1007/s11892-009-0035-4. Curr Diab Rep. 2009. PMID: 19490823 Review.
-
The β-cell glucose toxicity hypothesis: Attractive but difficult to prove.Metabolism. 2021 Nov;124:154870. doi: 10.1016/j.metabol.2021.154870. Epub 2021 Sep 1. Metabolism. 2021. PMID: 34480921 Free PMC article. Review.
-
The use of animal models in diabetes research.Br J Pharmacol. 2012 Jun;166(3):877-94. doi: 10.1111/j.1476-5381.2012.01911.x. Br J Pharmacol. 2012. PMID: 22352879 Free PMC article.
-
Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.J Clin Invest. 1998 Jun 1;101(11):2528-39. doi: 10.1172/JCI2401. J Clin Invest. 1998. PMID: 9616224 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous